Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 1996 Oct 15. 78(8):1781-8. [Medline].
Santarelli JG, Sarkissian V, Hou LC, Veeravagu A, Tse V. Molecular events of brain metastasis. Neurosurg Focus. 2007 Mar 15. 22(3):E1. [Medline].
Andrade AC, Ferruzzi DS, Panis C. Brain-metastatic breast cancer: clinical considerations and pharmacological approaches. Anticancer Agents Med Chem. 2016 Apr 4. [Medline].
Rusciano D, Burger MM. Mechanisms of Metastases. levine AJ, Schmidek HH (eds). In Molecular Genetics of Nervous System Tumors. New York: John Wiley & Son; 1993.
Nolte SM, Venugopal C, McFarlane N, Morozova O, Hallett RM, O'Farrell E. A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer. J Natl Cancer Inst. 2013 Feb 15. [Medline].
Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005 Dec 8. 438(7069):820-7. [Medline].
Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005 Dec 8. 438(7069):820-7. [Medline]. [Full Text].
Sheehan J. Radiosurgery for breast cancer. J Neurosurg. 2011 Mar. 114(3):790-1; discussion 791. [Medline].
Hanssens P, Karlsson B, Yeo TT, Chou N, Beute G. Detection of brain micrometastases by high-resolution stereotactic magnetic resonance imaging and its impact on the timing of and risk for distant recurrences. J Neurosurg. 2011 Sep. 115(3):499-504. [Medline].
Tien RD, Felsberg GJ, Friedman H, Brown M, MacFall J. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol. 1994 Mar. 162(3):671-7. [Medline].
Shonka N, Venur VA, Ahluwalia MS. Targeted Treatment of Brain Metastases. Curr Neurol Neurosci Rep. 2017 Apr. 17 (4):37. [Medline].
Galicich JH, French LA. Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract Dig Treat. 1961 Mar. 12:169-74. [Medline].
Park SJ, Kim HT, Lee DH, Kim KP, Kim SW, Suh C. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation. Lung Cancer. 2012 Sep. 77(3):556-60. [Medline].
Soffietti R, Trevisan E, Rudà R. Targeted therapy in brain metastasis. Curr Opin Oncol. 2012 Nov. 24(6):679-86. [Medline].
Verma J, Jonasch E, Allen P, Tannir N, Mahajan A. Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma. Cancer. 2011 Nov 1. 117(21):4958-65. [Medline].
Azim HA, Azim HA Jr. Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions. Future Oncol. 2012 Feb. 8(2):135-44. [Medline].
Mulcahy N. Spare the Hippocampus in Brain Radiotherapy, Preserve Memory. Available at http://www.medscape.com/viewarticle/811926. Accessed: October 7, 2013.
Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol. 2011. 6:48. [Medline].
Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg. 1993 Aug. 79(2):210-6. [Medline].
Cho KH, Hall WA, Lee AK. Stereotactic radiosurgery for patients with single brain metastasis. J Radiol. 1998. 1:79-85.
Auchter RM, Lamond JP, Alexander E, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996 Apr 1. 35(1):27-35. [Medline].
Nieder C, Mehta MP, Geinitz H, Grosu AL. Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms. Crit Rev Oncol Hematol. 2018 Jun. 126:13-18. [Medline].
Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997 Mar 1. 37(4):745-51. [Medline].
Bindal AK, Bindal RK, Hess KR, et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg. 1996 May. 84(5):748-54. [Medline].
DeAngelis LM, Mandell LR, Thaler HT, et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery. 1989 Jun. 24(6):798-805. [Medline].
Debinski W, Tatter SB. Convection-enhanced delivery for the treatment of brain tumors. Expert Rev Neurother. 2009 Oct. 9(10):1519-27. [Medline].
Harding A. Skipping Whole-Brain Radiation May Be OK With Multiple Metastases. Medscape Medical News. Available at http://www.medscape.com/viewarticle/822786. Accessed: April 7, 2014.
Jensen CA, Chan MD, McCoy TP, et al. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg. 2011 Jun. 114(6):1585-91. [Medline].
Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011 Jan 10. 29(2):134-41. [Medline]. [Full Text].
Lo SS, Sloan AE, Machtay M. Stereotactic radiosurgery for more than four brain metastases. Lancet Oncol. 2014 Apr. 15(4):362-3. [Medline].
Pullen LC. Biomarker identifies brain metastases in lung cancer patients. Medscape Medical News. November 20, 2013. [Full Text].
Rusciano D, Burger MM. Mechanisms of metastases. Levine AJ, Schmidek HH, eds. Molecular Genetics of Nervous System Tumors. New York, NY: Wiley-Liss; 1993.
Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014 Apr. 15(4):387-95. [Medline].